"COVID-19: What Pharmacists Need to Know" offers a multi-module CE webinar curriculum program that delivers current, credible information.
The curriculum features webinars on key issues related to the changing landscape of pharmacy practice in light of COVID-19, each with a different expert faculty presenter:
Webinar 1: "COVID-19 Basics and Effect on Pharmacy Practice," Rupal Mansukhani, Pharm.D., FAPhA, CTTS, on-demand webinar available here.
Webinar 2: "Existing and Investigational Pharmacotherapy for COVID-19," Jason C. Gallagher, Pharm.D., FCCP, FIDP, FIDSA, BCPS, on May 31, at 12:00 p.m. EST.
Webinar 3: "COVID-19: Industry's Response and Caring for Patients on the Front Line," Mary Barna Bridgeman, Pharm.D., BCPS, BCGP, on June 7, at 12:00 p.m. EST.
Webinar 4: "Psychosocial Effects and Quality of Life Impact of COVID-19," Mona K. Patel, Pharm.D., FCCM, BCCCP, on June 14, at 12:00 p.m. EST.
Webinar 5: "Update on COVID-19 Clinical Data and Impact on Reimbursement or Patient Access," Kelly E. Pillinger, Pharm.D., BCPS, BCIDP, on June 28, at 12:00 p.m. EST.
Completing these CE webinars will equip pharmacists with the most up-to-date data available on virology, emerging therapies and vaccines and patient management, as well as mental health, financial and quality of life burdens of COVID-19 on patients and health care personnel. Participants who complete all activities in this series will receive a certificate of completion.
Each activity is accredited by the Accreditation Council for Pharmacy Education and is approved for 0.75 contact hour (0.075 CEU).
This resource center is supported by an educational grant from Pfizer Inc.
Pharmacy Times Continuing Education is in continuing education for retail, health system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PTCE's print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team.
PTCE is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio
GSK and IQVIA expand vaccine track with local data to drive targeted public health action